Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

Hims & Hers vs Vaylen

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #92
Hims & Hers

Mass-market app-first program with nationwide polish — tirzepatide pricing disclosure lags the ranking.

Marked down on: Tirzepatide pricing inconsistently disclosed

FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.

vs
Dispatch #2Desk pick
Vaylen

The strongest all-rounder among the newer entrants — low pricing, brand access, oral routes, and all 50 states on one account.

Marked down on: Newer operator with a shorter track record

Vaylen takes this head-to-head with the higher Desk Score, 91/100 (A−) against 76/100 (C) for Hims & Hers. Hims & Hers still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Hims & Hers

76/100

C

Overall

Vaylen

91/100

A−

Price transparency

74
88

State access

94
96

Molecule range

74
96

Onboarding speed

80
86

Support responsiveness

74
84

Licensing & trust

76
90

The spec sheet

FieldHims & HersVaylen
Semaglutide$199/mo$179/mo
TirzepatideNot disclosed$239/mo
CoverageAll 50 statesAll 50 states
Brand-nameCompounded onlyYes
Oral optionInjectable onlyYes
Best forPeople who want a familiar consumer-brand app experience and don't need tirzepatide.People who want maximum optionality — brand or compounded, oral or injectable — without giving up nationwide reach.
Desk Score76/100C91/100A−

The verdict

Desk pick — Vaylen

Vaylen takes this head-to-head with the higher Desk Score, 91/100 (A−) against 76/100 (C) for Hims & Hers. Hims & Hers still holds its ground where its strengths line up with yours.

Choose Hims & Hers if…

People who want a familiar consumer-brand app experience and don't need tirzepatide.

$199/mo sema · Not disclosed tirz · All 50 states

FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.

Choose Vaylen if…

People who want maximum optionality — brand or compounded, oral or injectable — without giving up nationwide reach.

$179/mo sema · $239/mo tirz · All 50 states

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Hims & Hers · Vaylen.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.